Thomas Flament

ORCID: 0000-0003-0258-7856
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cystic Fibrosis Research Advances
  • COVID-19 Clinical Research Studies
  • Ultrasound in Clinical Applications
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Long-Term Effects of COVID-19
  • Lung Cancer Diagnosis and Treatment
  • Asthma and respiratory diseases
  • Tracheal and airway disorders
  • Cancer Immunotherapy and Biomarkers
  • Pleural and Pulmonary Diseases
  • COVID-19 and Mental Health
  • Neonatal Respiratory Health Research
  • COVID-19 and healthcare impacts
  • IgG4-Related and Inflammatory Diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Emergency and Acute Care Studies
  • Pediatric health and respiratory diseases
  • Respiratory viral infections research
  • Intensive Care Unit Cognitive Disorders
  • Respiratory Support and Mechanisms
  • Dysphagia Assessment and Management
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Palliative Care and End-of-Life Issues
  • COVID-19 diagnosis using AI
  • Lung Cancer Treatments and Mutations

Centre Hospitalier Universitaire de Tours
2015-2025

Société Française de Cardiologie
2021-2024

Johns Hopkins Hospital
2024

All India Institute of Medical Sciences Raipur
2023

All India Institute of Medical Sciences Rishikesh
2023

Hôpital Bretonneau
2018-2022

Thion Medical (France)
2019

Centre Hospitalier du Mans
2017

Canadian Respiratory Research Network
2016

Pierre‐Régis Burgel Isabelle Sermet‐Gaudelus Emmanuelle Girodon I. Durieu Véronique Houdouin and 95 more Camille Audousset Julie Macey Dominique Grenet Michele Porzio M. Murris‐Espin Philippe Reix Mélisande Baravalle Chantal Belleguic Laurent Mély Juliette Verhille Laurence Weiss Martine Reynaud‐Gaubert Marie Mittaine Rébecca Hamidfar Sophie Ramel Laure Cosson Benoît Douvry Isabelle Danner‐Boucher P. Foucaud Charlotte Roy Espérie Burnet Caroline Raynal M.‐P. Audrézet Jennifer Da Silva C. Martín Reem Kanaan Nicolas Carlier Isabelle Honoré Frédérique Chedevergne Elise Dréano Aurélie Hatton Alexandre Hinzpeter Iwona Pranke Laurence Le Clainche-Viala Sophie Mayer Harriet Corvol Guillaume Thouvenin Sandra de Miranda Natascha Remus Benoît Douvry L. Duthoit T. Pérez Olivier Le Rouzic Nathalie Wizla Claire Bon S. Bui Nora Poey Nathalie Stremler Bérengère Coltey Nadine Dufeu Jean Lebihan Asma Gabsi Delphine Pouradier Claire Andréjak Cinthia Rames Magali Dupuy-Grasset Jeanne Languepin Christophe Marguet S. Pramil Baptiste Arnouat Annlyse Fanton M. Abély Bruno Ravoninjatovo Aurore Blondé Anne Guillaumot Sébastien Kieffer Aurélie Tatopoulos R. Nove‐Josserand Camille Ohlmann Thomas Perrin Quitterie Reynaud C. Llerena S. Quétant Sophie Valois Marie‐Laure Dalphin Bénédicte Richaud-Thiriez Eric Deneuville R. Chiron Floriane Socchi Tiphaine Bihouée Julie Mankikian Thomas Flament Nathalie Coolen-Allou Elsa Gachelin Caroline Périsson Constance Vuillard Marion Dupuis Wael Alkoussa Sarah Marchal Sylvie Leroy Manuëla Scalbert Karine Campbell Muriel Laurans Guillaume Labbé Sylvie Montcouquiol

10.1016/s2213-2600(24)00208-x article EN The Lancet Respiratory Medicine 2024-08-13

Lung ultrasound holds high diagnostic performance for pleural diseases, notably pneumothorax. Bullous emphysema is a potential differential diagnosis of pneumothorax on ultrasound, but its precise semiology poorly known. This study aimed to delineate the sonographic presentation bullous and assess common features in identifying bullae. From June 2019 2021, patients with CT scanner-confirmed were prospectively included. Investigators performed standardised 14-region lung ultrasound....

10.1111/resp.70021 article EN cc-by Respirology 2025-03-09

To report efficacy and tolerance of nivolumab or pembrolizumab, PD-1 inhibitors, in people living with HIV (PLWHIV) cancer. Series PLWHIV cancer patients treated anti-PD1 agents real-life clinical practice. From May 2014 to January 2019, 575 HIV-infected have been discussed the French CANCERVIH national multidisciplinary board included network database. Twenty-three were immune checkpoint inhibitors daily We demographic characteristics, CD4 T-cell counts, viral loads, safety data these 23...

10.1097/qad.0000000000002298 article EN AIDS 2019-06-28

Gastro-oesophageal reflux has long been suspected of implication in the genesis and progression idiopathic pulmonary fibrosis (IPF). We hypothesised that hiatal hernia may be more frequent IPF than other interstitial lung disease (ILD), associated with severe clinical characteristics IPF.We retrospectively compared prevalence on computed tomographic (CT) scans 79 patients 103 ILD (17 scleroderma, 54 connective tissue diseases 32 chronic hypersensitivity pneumonitis). In group, we clinical,...

10.1183/13993003.01796-2015 article EN European Respiratory Journal 2016-05-12

Background In allergic bronchopulmonary aspergillosis (ABPA), prolonged nebulised antifungal treatment may be a strategy for maintaining remission. Methods We performed randomised, single-blind, clinical trial in 30 centres. Patients with controlled ABPA after 4-month attack (corticosteroids and itraconazole) were randomly assigned to liposomal amphotericin-B or placebo 6 months. The primary outcome was occurrence of first severe exacerbation within 24 months following randomisation....

10.1183/13993003.02218-2021 article EN European Respiratory Journal 2021-11-11

Purpose: To characterise patients with chronic obstructive pulmonary disease (COPD) who are rehospitalised for an acute exacerbation, to estimate the cost of these hospitalisations, high risk patient sub groups and identify factors potentially associated rehospitalisation. Patients Methods: This was a retrospective study using French National Hospital Discharge Database. All aged ≥ 40 years hospitalised exacerbation COPD between 2015 2016 were identified followed six months. at least one...

10.2147/copd.s236787 article EN cc-by-nc International Journal of COPD 2020-04-01

Abstract Background Diagnosis of acute exacerbation (AE) cystic fibrosis (CF) must be precise because both under‐ and over‐prescription antibiotics may detrimental. How lung function tests contribute to diagnose AE is unclear. We aimed describe variation spirometry oscillometry measurements, at Stable state in adults with CF. Methods Patients were included a retrospective single‐centre study when (FEV1, FVC) (X5, R5, R5−R20 AX) data available for least one visit between December 2016 July...

10.1111/cpf.12668 article EN Clinical Physiology and Functional Imaging 2020-10-03

Objective: High-resolution computed tomography (HRCT) may lack sensitivity for the early detection of interstitial lung disease associated with systemic sclerosis (SSc-ILD). Lung ultrasound is an emerging technique diagnosis SSc-ILD. This cross-sectional study aimed to describe prevalence syndrome in SSc patients normal HRCT and pulmonary function tests (PFT). Methods: Thirty HRCT, FVC > 80% predicted DLCO 70% were included. Echocardiography PFT including impulse oscillometry cardiopulmonary...

10.3390/jcm13102885 article EN Journal of Clinical Medicine 2024-05-14

<b>Introduction:</b> Parapneumonic pleuritis are frequently associated with high morbidity and severe sequelae. Management of this complication include early pleural evacuation. Guidelines do not currently recommend the use lung ultrasound (LUS) as an alternative to chest X-ray (CXR) or computerized tomography (CT) scan for diagnosis effusion. Chest x-ray is simplest diagnostic tool Community Acquired Pneumonia (CAP), but it has some limitation. Therefore, aim study evaluate sequelae LUS in...

10.1183/1393003.congress-2017.pa2116 preprint EN 2017-09-01
Coming Soon ...